21 May 2013
Keywords: analysts, view, pharma, revenue, exposure, japan, last
Article | 06 November 2006
Last month, the Japanese pharmaceutical analyst at Lehman Brothers lowered his Japanese pharmaceutical sector rating from 2-Neutral to
3-Negative to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 November 2006
20 May 2013
© 2013 thepharmaletter.com